Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

Racial Disparities in Pediatric Acute Myeloid Leukemia during Induction

Lena E. Winestone, MD, Kelly Diringer Getz, PhD, Tamara P. Miller, MD, Jennifer J. Wilkes, MD, Leah Sack, Yimei Li, PhD, Yuan-Shung Huang, Alix E. Seif, MD MPH, Rochelle Bagatell, MD, Brian T. Fisher, DO, MSCE, Andrew Epstein, PhD MPP, Richard Aplenc, MD PhD

Blood (2015) 126 (23): 530.

https://doi.org/10.1182/blood.V126.23.530.530

Published: 2015

Journal Articles

Patient Factors Associated with Enrollment on an Acute Myeloid Leukemia Phase III Clinical Trial: A Report from the Children’s Oncology Group

Pooja Rao, MD, Yimei Li, PhD, Todd A. Alonzo, PhD, Lillian Sung, MD PhD, Robert B. Gerbing, MA, Kelly D Getz, PhD, Alix E. Seif, MD MPH, Tamara P. Miller, MD, Yuan-Shung Huang, MS, Rochelle Bagatell, MD, Matthew Hall, PhD, Brian T. Fisher, DO, MSCE, Alan S. Gamis, MD MPH, Richard Aplenc, MD PhD

Blood (2014) 124 (21): 2286.

https://doi.org/10.1182/blood.V124.21.2286.2286

Published: 2014

Journal Articles

Resource Utilization and Cost Analysis By Treatment Arm on the Children’s Oncology Group AALL0232 Phase 3 High-Risk B-Precursor Acute Lymphoblastic Leukemia Trial: A Report from the Children’s Oncology Group

Amanda M. DiNofia, MD, Alix E. Seif, MD MPH, Meenakshi Devidas, PhD, Yimei Li, PhD, Matthew Hall, PhD, Yuan-Shung Vera Huang, MS, Rochelle Bagatell, MD, William L. Carroll, MD, Naomi J. Winick, MD, Stephen P. Hunger, MD, Brian T. Fisher, DO, MSCE, Eric C. Larsen, MD, Richard Aplenc, MD PhD

Blood (2014) 124 (21): 210.

https://doi.org/10.1182/blood.V124.21.210.210

Published: 2014

Journal Articles

Pediatric Hospital Volume and Induction Mortality in Pediatric Acute Lymphoblastic Leukemia (ALL)

Jennifer J. Wilkes, MD, Sean Hennessy, PharmD PhD, Rui Xiao, PhD, Susan R. Rheingold, MD, Alix E. Seif, MD MPH, Yuan-Shung Huang, MS, Neika Vendetti, MPH, Yimei Li, PhD, Rochelle Bagatell, MD, Richard Aplenc, MD PhD, Brian T. Fisher, DO, MSCE

Blood (2014) 124 (21): 2653.

https://doi.org/10.1182/blood.V124.21.2653.2653

Published: 2014

Journal Articles

Treatment Toxicity and Supportive Care Utilization in Children with Down Syndrome and Acute Lymphoid Leukemia at Free-Standing Pediatric Hospitals in the United States

Elizabeth K Goodman, AB, Yimei Li, PhD, Alix E. Seif, MD MPH, Julie Fitzgerald, MD PhD, Yuan-Shung Huang, MS, Rochelle Bagatell, MD, Brian T. Fisher, DO, MSCE, Richard Aplenc, MD PhD

Blood (2014) 124 (21): 553.

https://doi.org/10.1182/blood.V124.21.553.553

Published: 2014

Journal Articles

Comparison of Resource Utilization in Children Discharged Versus Children That Remain Hospitalized Following Chemotherapy for Acute Myeloid Leukemia

Kelly D Getz, PhD, Tamara P. Miller, MD, Alix E. Seif, MD MPH, Yimei Li, PhD, Yuan-Shung Huang, MS, Rochelle Bagatell, MD, Brian T. Fisher, DO, MSCE, Richard Aplenc, MD PhD

Blood (2014) 124 (21): 3697.

https://doi.org/10.1182/blood.V124.21.3697.3697

Published: 2014

Journal Articles

Variability in Antifungal Use for Pediatric Acute Myeloid Leukemia At Children's Hospitals Across the United States

Marko Kavcic, MD, Brian T. Fisher, DO, MSCE, Jeffrey S. Gerber, MD, PhD, Kateri H. Leckerman, MS, Yimei Li, PhD, Yuan-Shung Huang, MS, Alix E. Seif, MD, MPH, Kari Torp, Rochelle Bagatell, MD, Richard Aplenc, MD, PhD

Blood (2012) 120 (21): 4278.

https://doi.org/10.1182/blood.V120.21.4278.4278

Published: 2012

Journal Articles

Mortality and Resource Utilization in Children with De Novo Acute Myeloid Leukemia Treated with Chemotherapy and Gemtuzumab Ozogamicin in the United States

Marko Kavcic, MD, Brian T. Fisher, DO, MSCE, Yimei Li, PhD, Alix E. Seif, MD, MPH, Kari Torp, Yuan-Shung Huang, MS, Grace E. Lee, MD, Sarah K Tasian, MD, Ami V. Desai, MD, Marijana Vujkovic, PhD, Rochelle Bagatell, MD, Richard Aplenc, MD, PhD

Blood (2012) 120 (21): 4283.

https://doi.org/10.1182/blood.V120.21.4283.4283

Published: 2012

NARROW

Racial Disparities in Pediatric Acute Myeloid Leukemia during Induction

Patient Factors Associated with Enrollment on an Acute Myeloid Leukemia Phase III Clinical Trial: A Report from the Children’s Oncology Group

Resource Utilization and Cost Analysis By Treatment Arm on the Children’s Oncology Group AALL0232 Phase 3 High-Risk B-Precursor Acute Lymphoblastic Leukemia Trial: A Report from the Children’s Oncology Group

Pediatric Hospital Volume and Induction Mortality in Pediatric Acute Lymphoblastic Leukemia (ALL)

Treatment Toxicity and Supportive Care Utilization in Children with Down Syndrome and Acute Lymphoid Leukemia at Free-Standing Pediatric Hospitals in the United States

Comparison of Resource Utilization in Children Discharged Versus Children That Remain Hospitalized Following Chemotherapy for Acute Myeloid Leukemia

Variability in Antifungal Use for Pediatric Acute Myeloid Leukemia At Children's Hospitals Across the United States

Mortality and Resource Utilization in Children with De Novo Acute Myeloid Leukemia Treated with Chemotherapy and Gemtuzumab Ozogamicin in the United States

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only